Importantly, a recent study also showed that a distinct subpopulation of CD133+;CXCR4+ cancer stem cells (CSCs) was present at the leading edge of invasive pancreatic tumours, indicating a potential role of CXCR4 in the invasion process (Hermann et al, 2007). The gene discussed is CXCR4; the disease is pancreatic neoplasm.